XML 99 R85.htm IDEA: XBRL DOCUMENT v3.8.0.1

Concentrations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Concentration Risk [Line Items]
Total Revenues	$ 882,011	$ 13,391,492	$ 1,686,033
Less: revenues from discontinued operations		(329,119)	(947,732)
Revenues from continuing operations	882,011	13,062,373	738,301
Medical Devices [Member]
Concentration Risk [Line Items]
Total Revenues	827,032	1,305,372	1,500,957
Respiratory and Oxygen Homecare [Member]
Concentration Risk [Line Items]
Total Revenues		5,956	20,573
Mobile Medicine (sleep apnea diagnostic products) [Member]
Concentration Risk [Line Items]
Total Revenues	$ 54,979	$ 12,080,164	$ 164,503

X

- Definition

Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.

+ References

No definition available.

+ Details

Name:	llit_RevenuesDiscontinuedOperation
Namespace Prefix:	llit_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of regulated steam operating revenues recognized during the period.

+ References

No definition available.

+ Details

Name:	us-gaap_RegulatedOperatingRevenueSteam
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=llit_MedicalDevicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=llit_RespiratoryAndOxygenHomecareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=llit_MobileMedicineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: